CL2015000893A1 - Formulación de una forma farmacéutica sólida de desintegración rápida que comprende carbonato de calcio funcionalizado, un ingrediente activo y por lo menos un desintegrante; y método para su fabricación. - Google Patents

Formulación de una forma farmacéutica sólida de desintegración rápida que comprende carbonato de calcio funcionalizado, un ingrediente activo y por lo menos un desintegrante; y método para su fabricación.

Info

Publication number: CL2015000893A1
Authority: CL; Chile
Prior art keywords: disintegrant; formulation; manufacture; active ingredient; calcium carbonate
Prior art date: 2012-10-12

Application number

CL2015000893A

Other languages

English (en)

Inventor

Patrick A C Gane

Daniel E Gerard

Joachim Schoelkopf

Rainer Alles

Maxim Puchkov

Jörg Huwyler

Tanja Stirnimann

Original Assignee

Omya Int Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-10-12

Filing date

2015-04-09

Publication date

2015-08-28

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47022552&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2015000893(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2015-04-09 Application filed by Omya Int Ag filed Critical Omya Int Ag

2015-08-28 Publication of CL2015000893A1 publication Critical patent/CL2015000893A1/es

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C43/00—Compression moulding, i.e. applying external pressure to flow the moulding material; Apparatus therefor
- B29C43/006—Pressing and sintering powders, granules or fibres
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
- B29L2031/00—Other particular articles
- B29L2031/772—Articles characterised by their shape and not otherwise provided for

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Inorganic Chemistry (AREA)
Engineering & Computer Science (AREA)
Physiology (AREA)
Zoology (AREA)
Nutrition Science (AREA)
Mechanical Engineering (AREA)
Bioinformatics & Cheminformatics (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Medicinal Preparation (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Geology (AREA)
Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)

CL2015000893A 2012-10-12 2015-04-09 Formulación de una forma farmacéutica sólida de desintegración rápida que comprende carbonato de calcio funcionalizado, un ingrediente activo y por lo menos un desintegrante; y método para su fabricación. CL2015000893A1 (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP12188344.1A EP2719373B1 (en)	2012-10-12	2012-10-12	Fast disintegrating solid dosage form formulation comprising functionalized calcium carbonate and method of their manufacture
US201261713671P	2012-10-15	2012-10-15

Publications (1)

Publication Number	Publication Date
CL2015000893A1 true CL2015000893A1 (es)	2015-08-28

Family

ID=47022552

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CL2015000893A CL2015000893A1 (es)	2012-10-12	2015-04-09	Formulación de una forma farmacéutica sólida de desintegración rápida que comprende carbonato de calcio funcionalizado, un ingrediente activo y por lo menos un desintegrante; y método para su fabricación.

Country Status (27)

Country	Link
US (1)	US20150283082A1 (es)
EP (2)	EP2719373B1 (es)
JP (1)	JP6196676B2 (es)
KR (1)	KR101740835B1 (es)
CN (2)	CN104768531A (es)
AR (1)	AR092957A1 (es)
AU (1)	AU2013328639B2 (es)
BR (1)	BR112015008139B1 (es)
CA (1)	CA2884912C (es)
CL (1)	CL2015000893A1 (es)
CO (1)	CO7350657A2 (es)
DK (2)	DK2719373T3 (es)
ES (2)	ES2628371T3 (es)
HR (1)	HRP20191082T1 (es)
HU (1)	HUE044281T2 (es)
IL (1)	IL237766B (es)
MX (1)	MX369779B (es)
MY (1)	MY174635A (es)
PL (2)	PL2719373T3 (es)
PT (1)	PT2916816T (es)
RU (2)	RU2676087C2 (es)
SG (1)	SG11201502290SA (es)
SI (2)	SI2719373T1 (es)
TR (1)	TR201909173T4 (es)
TW (1)	TWI583387B (es)
UY (1)	UY35071A (es)
WO (1)	WO2014057038A1 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT2883573T (pt) *	2013-12-13	2018-01-04	Omya Int Ag	Composição de limpeza abrasiva
US10238598B2 (en)	2013-12-16	2019-03-26	The University Of British Columbia	Self-fueled particles for propulsion through flowing aqueous fluids
EP2921173A1 (en) *	2014-03-21	2015-09-23	Omya International AG	Surface-reacted calcium carbonate for desensitizing teeth
SG11201609445UA (en)	2014-05-30	2016-12-29	Omya Int Ag	Method for the production of granules comprising surface-reacted calcium carbonate
EP2957603A1 (en)	2014-06-20	2015-12-23	Omya International AG	Method for the production of granules comprising surface-reacted calcium carbonate
EP2949708B1 (en)	2014-05-30	2018-04-04	Omya International AG	Method for the production of granules comprising surface-reacted calcium carbonate
EP3034070A1 (en)	2014-12-18	2016-06-22	Omya International AG	Method for the production of a pharmaceutical delivery system
EP3069713A1 (en)	2015-03-20	2016-09-21	Omya International AG	Dispersible dosage form
EP3176222A1 (en) *	2015-12-01	2017-06-07	Omya International AG	Method for the production of granules comprising surface-reacted calcium carbonate
EP3260114A1 (en) *	2016-06-21	2017-12-27	Omya International AG	Method for the production of a dosage form
EP3260115A1 (en) *	2016-06-21	2017-12-27	Omya International AG	Method for the production of a dosage form
EP3269361A1 (en)	2016-07-14	2018-01-17	Omya International AG	Dosage form
EP3275537A1 (en) *	2016-07-25	2018-01-31	Omya International AG	Surface-modified calcium carbonate as carrier for transition metal-based catalysts
EP3275946A1 (en) *	2016-07-25	2018-01-31	Omya International AG	Post treatment of surface-reacted calcium carbonate with different functional cations
EP3400810A1 (en) *	2017-05-11	2018-11-14	Omya International AG	Surface-reacted calcium carbonate in food
EP3594289A1 (en) *	2018-07-13	2020-01-15	Omya International AG	Surface-reacted calcium carbonate for stabilizing mint oil
EP3622966A1 (en)	2018-09-17	2020-03-18	Omya International AG	High performance excipient comprising co-processed microcrystalline cellulose and surface-reacted calcium carbonate
EP3682901A1 (en)	2019-01-21	2020-07-22	Omya International AG	High performance excipient comprising co-processed microcrystalline cellulose and surface-reacted calcium carbonate
EP3852807B1 (en)	2018-09-17	2023-05-03	Omya International AG	High performance excipient comprising co-processed microcrystalline cellulose and surface-reacted calcium carbonate
CN109749745A (zh) *	2018-12-21	2019-05-14	西北农林科技大学	一种利用土体固化溶液加固土体的方法
US11113797B1 (en)	2019-08-19	2021-09-07	Snap Inc.	Passive flash imaging
IL297604A (en)	2020-04-28	2022-12-01	Omya Int Ag	A method for producing free-flowing granules
TW202200206A (zh)	2020-04-28	2022-01-01	瑞士商歐米亞國際公司	包含表面反應碳酸鈣作為賦形劑之顆粒
EP4157979B1 (en) *	2020-05-28	2024-04-24	Unilever IP Holdings B.V.	Tablet
BE1031271B1 (nl) *	2023-01-19	2024-08-19	Herdt Kris De	Tablet ter verhoging van de bufferende werking van water

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2556561C2 (de)	1975-12-16	1983-04-14	Boehringer Mannheim Gmbh, 6800 Mannheim	Verfahren zur Herstellung von porösen Tabletten
US4650699A (en) *	1983-04-18	1987-03-17	Sermetel	Thixotropic alumina coating compositions, parts and methods
US5595761A (en)	1994-01-27	1997-01-21	The Board Of Regents Of The University Of Oklahoma	Particulate support matrix for making a rapidly dissolving tablet
US6066337A (en)	1994-01-27	2000-05-23	The Board Of Regents Of The University Of Oklahoma And Janssen Pharmaceutica, Inc.	Method for producing a rapidly dissolving dosage form
US5635210A (en)	1994-02-03	1997-06-03	The Board Of Regents Of The University Of Oklahoma	Method of making a rapidly dissolving tablet
FR2787802B1 (fr)	1998-12-24	2001-02-02	Pluss Stauffer Ag	Nouvelle charge ou pigment ou mineral traite pour papier, notamment pigment contenant du caco3 naturel, son procede de fabrication, compositions les contenant, et leurs applications
FR2852600B1 (fr)	2003-03-18	2005-06-10		Nouveau pigment mineral contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages
US20050244493A1 (en) *	2004-04-30	2005-11-03	Withiam Michael C	Rapidly disintegrating tablets comprising calcium carbonate
DK2070991T3 (da)	2007-12-12	2010-12-20	Omya Development Ag	Fremgangsmåde til frembringelse af overflademodificeret, udfældet calciumcarbonat
JP5490691B2 (ja) *	2008-06-12	2014-05-14	株式会社三和化学研究所	炭酸カルシウム含有速崩壊性製剤
EP2168572A1 (en) *	2008-09-30	2010-03-31	Omya Development Ag	New controlled release active agent carrier
EP2198857A1 (en) *	2008-12-19	2010-06-23	Ratiopharm GmbH	Oral dispersible tablet
KR101565621B1 (ko) *	2009-01-26	2015-11-03	신에쓰 가가꾸 고교 가부시끼가이샤	저치환도 히드록시프로필셀룰로오스 수분산액을 이용한 습식 조립 타정법
JP4562797B1 (ja) *	2009-05-29	2010-10-13	マイラン製薬株式会社	沈降炭酸カルシウムを有効成分とする口腔内崩壊錠
SI2264108T1 (sl)	2009-06-15	2012-06-29	Omya Development Ag	Postopek za pripravo povrĹˇinsko reakcijsko obdelanega kalcijevega karbonata ob uporabi Ĺˇibke kisline
SI2377900T1 (sl) *	2010-04-16	2013-12-31	Omya International Ag	Postopek za pripravo površinsko modificiranega mineralnega materiala, izhajajoči proizvodi in njihova uporaba

2012
- 2012-10-12 SI SI201230974A patent/SI2719373T1/sl unknown
- 2012-10-12 DK DK12188344.1T patent/DK2719373T3/en active
- 2012-10-12 EP EP12188344.1A patent/EP2719373B1/en active Active
- 2012-10-12 PL PL12188344T patent/PL2719373T3/pl unknown
- 2012-10-12 ES ES12188344.1T patent/ES2628371T3/es active Active
2013
- 2013-10-01 TW TW102135466A patent/TWI583387B/zh active
- 2013-10-09 UY UY0001035071A patent/UY35071A/es not_active Application Discontinuation
- 2013-10-09 AR ARP130103663A patent/AR092957A1/es not_active Application Discontinuation
- 2013-10-10 RU RU2015115916A patent/RU2676087C2/ru active
- 2013-10-10 HR HRP20191082TT patent/HRP20191082T1/hr unknown
- 2013-10-10 EP EP13774204.5A patent/EP2916816B1/en active Active
- 2013-10-10 MY MYPI2015701128A patent/MY174635A/en unknown
- 2013-10-10 TR TR2019/09173T patent/TR201909173T4/tr unknown
- 2013-10-10 DK DK13774204.5T patent/DK2916816T3/da active
- 2013-10-10 ES ES13774204T patent/ES2732841T3/es active Active
- 2013-10-10 KR KR1020157010108A patent/KR101740835B1/ko active Active
- 2013-10-10 PT PT13774204T patent/PT2916816T/pt unknown
- 2013-10-10 AU AU2013328639A patent/AU2013328639B2/en active Active
- 2013-10-10 SG SG11201502290SA patent/SG11201502290SA/en unknown
- 2013-10-10 SI SI201331489T patent/SI2916816T1/sl unknown
- 2013-10-10 JP JP2015536128A patent/JP6196676B2/ja active Active
- 2013-10-10 WO PCT/EP2013/071169 patent/WO2014057038A1/en not_active Ceased
- 2013-10-10 PL PL13774204T patent/PL2916816T3/pl unknown
- 2013-10-10 CA CA2884912A patent/CA2884912C/en active Active
- 2013-10-10 CN CN201380052937.7A patent/CN104768531A/zh active Pending
- 2013-10-10 MX MX2015004234A patent/MX369779B/es active IP Right Grant
- 2013-10-10 RU RU2018127317A patent/RU2018127317A/ru unknown
- 2013-10-10 CN CN201910889639.2A patent/CN110742867A/zh active Pending
- 2013-10-10 US US14/428,052 patent/US20150283082A1/en not_active Abandoned
- 2013-10-10 BR BR112015008139-8A patent/BR112015008139B1/pt active IP Right Grant
- 2013-10-10 HU HUE13774204 patent/HUE044281T2/hu unknown
2015
- 2015-03-16 IL IL237766A patent/IL237766B/en unknown
- 2015-04-09 CL CL2015000893A patent/CL2015000893A1/es unknown
- 2015-04-14 CO CO15082672A patent/CO7350657A2/es unknown

Also Published As

Publication number	Publication date
KR101740835B1 (ko)	2017-05-26
AU2013328639B2 (en)	2016-09-15
WO2014057038A1 (en)	2014-04-17
UY35071A (es)	2014-05-30
TWI583387B (zh)	2017-05-21
MY174635A (en)	2020-05-04
AU2013328639A1 (en)	2015-04-02
EP2719373B1 (en)	2017-04-19
JP2015533140A (ja)	2015-11-19
BR112015008139A2 (pt)	2017-07-04
RU2018127317A (ru)	2019-03-14
PL2916816T3 (pl)	2019-09-30
BR112015008139B1 (pt)	2022-06-07
CA2884912C (en)	2018-01-02
CN104768531A (zh)	2015-07-08
RU2015115916A (ru)	2016-11-27
IL237766A0 (en)	2015-05-31
EP2916816B1 (en)	2019-03-27
EP2719373A1 (en)	2014-04-16
SI2916816T1 (sl)	2019-08-30
RU2676087C2 (ru)	2018-12-26
PL2719373T3 (pl)	2017-10-31
CO7350657A2 (es)	2015-08-10
CA2884912A1 (en)	2014-04-17
MX369779B (es)	2019-11-21
AR092957A1 (es)	2015-05-06
US20150283082A1 (en)	2015-10-08
DK2719373T3 (en)	2017-07-03
EP2916816A1 (en)	2015-09-16
IL237766B (en)	2021-07-29
HRP20191082T1 (hr)	2019-10-18
MX2015004234A (es)	2015-06-10
JP6196676B2 (ja)	2017-09-13
CN110742867A (zh)	2020-02-04
SG11201502290SA (en)	2015-04-29
PT2916816T (pt)	2019-06-28
DK2916816T3 (da)	2019-07-01
TW201438722A (zh)	2014-10-16
KR20150063444A (ko)	2015-06-09
HUE044281T2 (hu)	2019-10-28
ES2628371T3 (es)	2017-08-02
ES2732841T3 (es)	2019-11-26
AU2013328639A8 (en)	2015-05-14
TR201909173T4 (tr)	2019-07-22
RU2018127317A3 (es)	2022-03-24
SI2719373T1 (sl)	2017-07-31

Publication	Publication Date	Title
CL2015000893A1 (es)	2015-08-28	Formulación de una forma farmacéutica sólida de desintegración rápida que comprende carbonato de calcio funcionalizado, un ingrediente activo y por lo menos un desintegrante; y método para su fabricación.
BR112015001098A2 (pt)	2017-08-08	composto, composição farmacêutica e método para o tratamento de uma condição de doença.
BRPI0914918A2 (pt)	2015-10-20	forma de dosagem farmacêutica, e, método para preparar uma forma de dosagem sólida.
CL2013001586A1 (es)	2013-11-29	Composicion microgranular de rapida dispersion que comprende al menos un alcohol de azucar, un sacarido, o una mezcla de estos, al menos un super disgregante y al menos un aditivo multifuncion; comprimido de desintegracion oral que comprende la composicion microgranular y al menos un principio activo; y metodos de fabricacion.
BRPI1016132A2 (pt)	2016-04-19	composição, formulação farmacêutica, método para fabricar uma formulação farmacêutica estável.
BR112014026149A2 (pt)	2017-07-18	método para a preparação de 2,4-ácido dihidroxibutírico (2,4-dhb) e microrganismo.
BR112015001577A2 (pt)	2017-07-04	agente de emulsificação, produto alimentício, método para a fabricação de um produto alimentício e agente de emulsificação e de estabilização.
BR112013010102A2 (pt)	2016-09-06	microagulha, arranjo de microagulhas, dispositivo de microagulhas, e, método para administrar um agente medicinal
HUE037742T2 (hu)	2018-09-28	Szubsztituált azolok, vírusellenes aktív adalék, gyógyszerészeti készítmény, az elõállításukat célzó eljárás és alkalmazásuk
CL2014003332A1 (es)	2015-02-27	Una composicion que comprende un plaguicida solido insoluble en agua, un plaguicida soluble en agua, un agente reologico y un agente humectante-dispersante.
DK2667856T3 (da)	2021-08-30	Medicinsk indretning indeholdende en tørstofsammensætning omfattende aripiprazol som en aktiv ingrediens, og en tørstofsammensætning omfattende aripiprazol som en aktiv ingrediens
IL229204A (en)	2016-11-30	Hydroxystilbins that carry paranilations, medicinal preparations and their uses
PL3003285T3 (pl)	2022-06-20	Stała farmaceutyczna postać dawkowania do uwalniania co najmniej dwóch substancji czynnych w jamie ustnej
CL2014002414A1 (es)	2015-04-06	Composicion farmaceutica inyectable que comprende ibuprofeno, una solucion acuosa y un agente solubilizante seleccionado de fosfatos de sodio, de potasio, carbonatos de sodio, de potasio y/o combinaciones de ellos.
BR112015001843A2 (pt)	2017-07-04	dispositivo médico, composição de matriz biodegradável e método para tratar um paciente.
PT2900251T (pt)	2017-01-18	Novos extratos de cynara scolymus, coffea spp. e olea europaea para o tratamento da síndrome metabólica
BR112014001999A2 (pt)	2017-02-21	composição farmacêutica, forma de dosagem unitária, formulação de granulação a úmido, formulação de compactação por roletes, formulação de compressão direta, e, método para a preparação de uma composição farmacêutica
CL2013001684A1 (es)	2014-01-10	Composicion farmaceutica de administracion oral que comprende alisporivir, un componente lipofilico, un tensoactivo y un componente hidrofilico.
BR112012005938A2 (pt)	2016-03-15	formas de dosagem, e, processo para produzir preparações para formas de dosagem de ingredientes ativos de baixa solubilidade em água
CL2013001626A1 (es)	2013-10-04	Composicion farmaceutica para la prevención y el tratamiento de una cardiovasculopatia que comprende clorhidrato de lercanidipina y valsartan; metodo para la preparacion de la misma.
BR112015014576A2 (pt)	2018-04-24	cunha de válvula, e método para a fabricação de uma cunha de válvula
BRPI1014029A2 (pt)	2015-08-25	Formulações e métodos para misturas contendo quitossana sólida.
NZ702849A (en)	2016-09-30	Genotype- or phenotype-based drug formulation
MX2015006011A (es)	2015-09-10	Pastilla medicinal a base de ibuprofeno sodico dihidratado.
CL2015000402A1 (es)	2015-06-05	Formulación de comprimidos compuestos de dos fases que comprende irbesartan, atorvastatina y carbonato de magnesio; metodo de preparacion.